Sort   by:  
 Page size 
UnknownDiscovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed de novo design model.
Not available
S-EPMC8204246 | biostudies-literature
UnknownTurning high-throughput structural biology into predictive inhibitor design.
Not available
S-EPMC10089178 | biostudies-literature
UnknownExpanding the Repertoire of Low-Molecular-Weight Pentafluorosulfanyl-Substituted Scaffolds.
Not available
S-EPMC9305131 | biostudies-literature
UnknownAn automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.
Not available
S-EPMC8228784 | biostudies-literature
UnknownAn in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition.
Not available
S-EPMC10027274 | biostudies-literature
UnknownOpen science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
Not available
S-EPMC7615835 | biostudies-literature
UnknownHit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor.
Not available
S-EPMC9003389 | biostudies-literature
UnknownSARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids.
Not available
S-EPMC8709832 | biostudies-literature
Sort   by:  
 Page size